Annual CAPEX
$3.48 M
+$1.33 M+62.00%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual capital expenditures is currently $3.48 million, with the most recent change of +$1.33 million (+62.00%) on 31 December 2023. During the last 3 years, it has risen by +$3.12 million (+862.15%). EYPT annual CAPEX is now at all-time high.EYPT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.57 M
+$674.00 K+74.89%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly capital expenditures is currently $1.57 million, with the most recent change of +$674.00 thousand (+74.89%) on 30 September 2024. Over the past year, it has dropped by -$146.00 thousand (-8.49%). EYPT quarterly CAPEX is now -8.49% below its all-time high of $1.72 million, reached on 30 September 2023.EYPT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$4.55 M
-$146.00 K-3.11%
30 September 2024
Summary:
EyePoint Pharmaceuticals TTM capital expenditures is currently $4.55 million, with the most recent change of -$146.00 thousand (-3.11%) on 30 September 2024. Over the past year, it has increased by +$1.37 million (+42.89%). EYPT TTM CAPEX is now -3.11% below its all-time high of $4.70 million, reached on 30 June 2024.EYPT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.0% | -8.5% | +42.9% |
| 3 y3 years | +862.1% | +1101.5% | +1207.8% |
| 5 y5 years | +2538.6% | +100.0% | +2098.6% |
EYPT CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2132.7% | -8.5% | -3.1% | +2817.3% | |
| 5 y | 5 years | at high | +2538.6% | -8.5% | -3.1% | +9583.0% | |
| alltime | all time | at high | >+9999.0% | -8.5% | >+9999.0% | -3.1% | >+9999.0% |
EyePoint Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.57 M(+74.9%) | $4.55 M(-3.1%) |
| June 2024 | - | $900.00 K(-24.6%) | $4.70 M(+12.0%) |
| Mar 2024 | - | $1.19 M(+35.2%) | $4.19 M(+20.4%) |
| Dec 2023 | $3.48 M(+62.0%) | $883.00 K(-48.7%) | $3.48 M(+9.4%) |
| Sept 2023 | - | $1.72 M(+334.3%) | $3.19 M(+19.6%) |
| June 2023 | - | $396.00 K(-18.2%) | $2.66 M(+7.2%) |
| Mar 2023 | - | $484.00 K(-17.3%) | $2.48 M(+15.6%) |
| Dec 2022 | $2.15 M(+1278.2%) | $585.00 K(-51.2%) | $2.15 M(+37.4%) |
| Sept 2022 | - | $1.20 M(+449.5%) | $1.56 M(+214.3%) |
| June 2022 | - | $218.00 K(+46.3%) | $498.00 K(+63.3%) |
| Mar 2022 | - | $149.00 K(>+9900.0%) | $305.00 K(+95.5%) |
| Dec 2021 | $156.00 K(-56.9%) | $0.00(-100.0%) | $156.00 K(-55.2%) |
| Sept 2021 | - | $131.00 K(+424.0%) | $348.00 K(+0.9%) |
| June 2021 | - | $25.00 K(-87.0%) | $345.00 K(-4.7%) |
| Dec 2020 | $362.00 K(+70.0%) | $192.00 K(+50.0%) | $362.00 K(+105.7%) |
| Sept 2020 | - | $128.00 K(+392.3%) | $176.00 K(+266.7%) |
| June 2020 | - | $26.00 K(+62.5%) | $48.00 K(+2.1%) |
| Mar 2020 | - | $16.00 K(+166.7%) | $47.00 K(-77.9%) |
| Dec 2019 | $213.00 K(+61.4%) | $6000.00(>+9900.0%) | $213.00 K(+2.9%) |
| Sept 2019 | - | $0.00(-100.0%) | $207.00 K(-34.5%) |
| June 2019 | - | $25.00 K(-86.3%) | $316.00 K(-6.0%) |
| Mar 2019 | - | $182.00 K(+67.0%) | $336.00 K(+119.6%) |
| Dec 2018 | $132.00 K(+22.2%) | - | - |
| Sept 2018 | - | $109.00 K(+142.2%) | $153.00 K(+41.7%) |
| June 2018 | $108.00 K(-26.5%) | $45.00 K(-4600.0%) | $108.00 K(-42.9%) |
| Mar 2018 | - | -$1000.00(<-9900.0%) | $189.00 K(-8.3%) |
| Dec 2017 | - | $0.00(-100.0%) | $206.00 K(-2.4%) |
| Sept 2017 | - | $64.00 K(-49.2%) | $211.00 K(+43.5%) |
| June 2017 | $147.00 K(+30.1%) | $126.00 K(+687.5%) | $147.00 K(+119.4%) |
| Mar 2017 | - | $16.00 K(+220.0%) | $67.00 K(-18.3%) |
| Dec 2016 | - | $5000.00(-89.1%) | $82.00 K(-27.4%) |
| June 2016 | $113.00 K(-29.8%) | $46.00 K(+48.4%) | $113.00 K(-28.0%) |
| Mar 2016 | - | $31.00 K(+24.0%) | $157.00 K(-7.1%) |
| Dec 2015 | - | $25.00 K(+127.3%) | $169.00 K(+1.8%) |
| Sept 2015 | - | $11.00 K(-87.8%) | $166.00 K(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | $161.00 K(-35.1%) | $90.00 K(+109.3%) | $161.00 K(-34.0%) |
| Mar 2015 | - | $43.00 K(+95.5%) | $244.00 K(-4.3%) |
| Dec 2014 | - | $22.00 K(+266.7%) | $255.00 K(+3.7%) |
| Sept 2014 | - | $6000.00(-96.5%) | $246.00 K(-0.8%) |
| June 2014 | $248.00 K(+264.7%) | $173.00 K(+220.4%) | $248.00 K(+163.8%) |
| Mar 2014 | - | $54.00 K(+315.4%) | $94.00 K(+77.4%) |
| Dec 2013 | - | $13.00 K(+62.5%) | $53.00 K(-26.4%) |
| Sept 2013 | - | $8000.00(-57.9%) | $72.00 K(+5.9%) |
| June 2013 | $68.00 K(-83.2%) | $19.00 K(+46.2%) | $68.00 K(+23.6%) |
| Mar 2013 | - | $13.00 K(-59.4%) | $55.00 K(-9.8%) |
| Dec 2012 | - | $32.00 K(+700.0%) | $61.00 K(-67.6%) |
| Sept 2012 | - | $4000.00(-33.3%) | $188.00 K(-53.6%) |
| June 2012 | $405.00 K(+204.5%) | $6000.00(-68.4%) | $405.00 K(-12.7%) |
| Mar 2012 | - | $19.00 K(-88.1%) | $464.00 K(+2.2%) |
| Dec 2011 | - | $159.00 K(-28.1%) | $454.00 K(+31.6%) |
| Sept 2011 | - | $221.00 K(+240.0%) | $345.00 K(+159.4%) |
| June 2011 | $133.00 K(+786.7%) | $65.00 K(+622.2%) | $133.00 K(+95.6%) |
| Mar 2011 | - | $9000.00(-82.0%) | $68.00 K(+15.3%) |
| Dec 2010 | - | $50.00 K(+455.6%) | $59.00 K(+555.6%) |
| Sept 2010 | - | $9000.00(-57.1%) | $9000.00(-95.4%) |
| June 2010 | $15.00 K(-92.3%) | - | - |
| June 2009 | $195.00 K(-28.3%) | $21.00 K(+16.7%) | $195.00 K(-37.7%) |
| Mar 2009 | - | $18.00 K(-63.3%) | $313.00 K(-7.7%) |
| Dec 2008 | - | $49.00 K(-54.2%) | $339.00 K(+14.1%) |
| Sept 2008 | - | $107.00 K(-23.0%) | $297.00 K(+9.2%) |
| June 2008 | $272.00 K(+231.7%) | $139.00 K(+215.9%) | $272.00 K(+104.5%) |
| Mar 2008 | - | $44.00 K(+528.6%) | $133.00 K(+49.4%) |
| Dec 2007 | - | $7000.00(-91.5%) | $89.00 K(+8.5%) |
| Sept 2007 | - | $82.00 K | $82.00 K |
| June 2007 | $82.00 K(-92.9%) | - | - |
| June 2006 | $1.15 M(-55.4%) | - | - |
| June 2005 | $2.59 M(+607.0%) | - | - |
| June 2004 | $366.30 K(+928.9%) | - | - |
| June 2003 | $35.60 K(-37.7%) | - | - |
| June 2001 | $57.10 K | - | - |
FAQ
- What is EyePoint Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual CAPEX year-on-year change?
- What is EyePoint Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly CAPEX year-on-year change?
- What is EyePoint Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM CAPEX year-on-year change?
What is EyePoint Pharmaceuticals annual capital expenditures?
The current annual CAPEX of EYPT is $3.48 M
What is the all time high annual CAPEX for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual capital expenditures is $3.48 M
What is EyePoint Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, EYPT annual capital expenditures has changed by +$1.33 M (+62.00%)
What is EyePoint Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of EYPT is $1.57 M
What is the all time high quarterly CAPEX for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly capital expenditures is $1.72 M
What is EyePoint Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, EYPT quarterly capital expenditures has changed by -$146.00 K (-8.49%)
What is EyePoint Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of EYPT is $4.55 M
What is the all time high TTM CAPEX for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM capital expenditures is $4.70 M
What is EyePoint Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, EYPT TTM capital expenditures has changed by +$1.37 M (+42.89%)